Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (371-380 of 393) with videos related to

Pageof 40
Sort By:
British Journal of Cancer|August 27, 2022
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumourTatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, et al.
Annals of Surgical Oncology|April 14, 2021
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working GroupCarol J Swallow, Dirk C Strauss, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european studyFabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2023
Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]Fabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2022
Correction to: Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2022
Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Pageof 40

Showing results (371-380 of 393) with videos related to

Sort By:
Pageof 40
British Journal of Cancer|August 27, 2022
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumourTatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, et al.
Annals of Surgical Oncology|April 14, 2021
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working GroupCarol J Swallow, Dirk C Strauss, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european studyFabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2023
Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]Fabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2022
Correction to: Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2022
Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Pageof 40